Literature DB >> 20421621

Teratogenic causes of malformations.

Enid Gilbert-Barness1.   

Abstract

Crucial morphogenetic processes during the blastogenesis period, which extends throughout the first 4 wk of development, from fertilization until the end of the gastrulation stage (days 27 to 28 postconception), can be altered and result in structural abnormalities, including patterns of multiple congenital anomalies (MCAs) arising from developmental field defects. Severe damage may cause death of the product of conception or, because of the pluripotential nature of the cells, the damage may be compensated allowing development to continue in a normal fashion. Most investigators believe that the all-or-none rule applies to the first 2 wk of development. Because the fetus is less susceptible to morphologic alterations when the developmental process of the majority of organs has been completed, the most common anomalies associated with teratogenic exposures during the fetal period are fetal growth restriction (intrauterine growth retardation) and mild errors of morphogenesis (abnormalities of phenogenesis), such as epicanthic folds, clinodactyly, and others. Thus, teratogenic exposures result in a wide variety of effects that range from infertility, prenatal onset growth restriction, structural defects, and functional CNS abnormalities to miscarriage or fetal death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421621

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  32 in total

1.  Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia.

Authors:  Dana M Cairns; Robert J Pignolo; Tomoya Uchimura; Tracy A Brennan; Carter M Lindborg; Meiqi Xu; Frederick S Kaplan; Eileen M Shore; Li Zeng
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 2.  Teratogen screening with human pluripotent stem cells.

Authors:  Kathryn E Worley; Jennifer Rico-Varela; Dominic Ho; Leo Q Wan
Journal:  Integr Biol (Camb)       Date:  2018-09-17       Impact factor: 2.192

3.  Zebrafish as a Model to Assess the Teratogenic Potential of Nitrite.

Authors:  Vishal Keshari; Basma Adeeb; Alison E Simmons; Thomas W Simmons; Cuong Q Diep
Journal:  J Vis Exp       Date:  2016-02-16       Impact factor: 1.355

4.  Histology Atlas of the Developing Mouse Urinary System With Emphasis on Prenatal Days E10.5-E18.5.

Authors:  Susan A Elmore; Sanam L Kavari; Mark J Hoenerhoff; Beth Mahler; Brittany E Scott; Koichi Yabe; John C Seely
Journal:  Toxicol Pathol       Date:  2019-10-10       Impact factor: 1.902

5.  Zebrafish retinal defects induced by ethanol exposure are rescued by retinoic acid and folic acid supplement.

Authors:  Pooja Muralidharan; Swapnalee Sarmah; James A Marrs
Journal:  Alcohol       Date:  2014-11-26       Impact factor: 2.405

6.  Gestational di-n-butyl phthalate exposure induced developmental and teratogenic anomalies in rats: a multigenerational assessment.

Authors:  P Mahaboob Basha; M J Radha
Journal:  Environ Sci Pollut Res Int       Date:  2016-12-12       Impact factor: 4.223

7.  HYDROCEPHALY, SCHIZENCEPHALY, SPONDYLOCOSTAL DYSPLASIA, AND HYPOPARATHYROIDISM IN AN INFANT OF A DIABETIC MOTHER.

Authors:  L Ognean; O Boanta; G Visa; F Grosu; C Şofariu; M Gafencu; C Matei; S Iurian
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

Review 8.  Maternal hyperglycemia and fetal cardiac development: Clinical impact and underlying mechanisms.

Authors:  Madhumita Basu; Vidu Garg
Journal:  Birth Defects Res       Date:  2018-12-01       Impact factor: 2.344

Review 9.  The role of glucose in physiological and pathological heart formation.

Authors:  Haruko Nakano; Viviana M Fajardo; Atsushi Nakano
Journal:  Dev Biol       Date:  2021-02-10       Impact factor: 3.148

10.  Oxidative stress is increased in women with epilepsy: Is it a potential mechanism of anti-epileptic drug-induced teratogenesis?

Authors:  Damayanthi Deepa; Narayani Jayakumari; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.